Patent Analytics Webinar

in association with


Antiviral Patents - How prepared are we to combat novel

viral diseases?


02. April | Thursday | 18:00 CET | 12:00 pm (noon) ET

Register Now - white-1


The technology landscape of Antiviral drugs

About the Webinar

With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing  both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes  that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.

Join our webinar to learn more about:

  • The entire technology field and key players in antiviral vaccine market
  • Review of selected companies who have technologies related to coronavirus
  • Portfolio landscaping of global pharma leaders in this technology field
  • How PatentSight metrics evaluate the portfolio strength


Gene Quinn
Gene Quinn

Gene Quinn is the President and founder of, a patent attorney, law professor, and leading commentator on patent law and innovation policy. Gene’s writing typically focuses on pending legislation, rule making at the United States Patent and Trademark Office, and general commentary about the state of the industry. Gene practices patent law with Widerman Malek, and the majority of his patent practice is focused on software patents and Internet innovations. Since 2000 he has also been a principal lecturer in the PLI Patent Bar Review Course.

An expert from a leading pharmaceutical company will join the panel

More information to be added soon.

Panelist from leading pharmaceutical company
Leading Position
Top pharmaceutical company
Will Mansfield
William Mansfield
Head of Consulting and Customer Success
LexisNexis® PatentSight®

William Mansfield is the Head of Consulting and Customer Success at LexisNexis® PatentSight®. He is responsible for overseeing the negotiation, creation, and delivery of PatentSight’s global consulting projects, along with managing the Customer Success team. He works closely with numerous international and Fortune 500 companies to ensure effective deployment of patent analyses for Business Strategy, M&A Due Diligence, Portfolio Management, and other cases. With an Economics background and experience in Market and R&D strategy in the semiconductor industry, Will approaches patent analytics with an eye on business value creation.

Register for this webinar


Antiviral Patents - How prepared are we to combat novel viral diseases?

02. April | Thursday | 18:00 CET | 12:00 pm (noon) ET


Please fill up this form and click on submit to register for the webinar. Shortly after you click on submit, you will receive an email confirmation from 'GoToWebinar', confirming your registration. This email will also contain further information regarding the procedure to follow to join the webinar, links to download presentation material, etc.
If you did not receive a confirmation email or have any other questions regarding this webinar, please contact us at: 
Please note: If you are unable to attend the live webinar session, we will send you a link to the recording, which you can watch according to your schedule. Please make sure to register by filling out the form and clicking on submit. Only then can we send you the link by email, as soon as we have uploaded the recording.

Who should attend this webinar:

  • IP professionals
  • R&D executives
  • Competitive intelligence experts
  • Bio-tech strategists
  • Anyone interested in antiviral and COVID-19 developments

Register for this Webinar